<p>Distribution of the 3682 IVD tests versus the TPS used and the treatment technique (VMAT or IMRT) adopted.</p
<p>Distribution of the CHA<sub>2</sub>DS<sub>2</sub>-VASc and the HAS-BLED Score of all patients on ...
<p>Distribution of episodes by number of lines of treatment contained therein, compared for TRD and ...
<p>Distribution of reported false and indeterminate results by tester profession in PT1 and PT2.</p
<p>Percentage of IVD tests T% with indices , , and within tolerance levels for different treatment ...
Distribution of mild, moderate, and severe patients, based on the five approaches used in the study....
<p>The reported legend in the figure shows the dose distribution considered in this plan.</p
Distribution of cases in the training sets obtained from different hospitals (A-D).</p
Distribution of the experimental groups according to treatment received, ethanasia times, and treatm...
Distribution of surrogate measures for insulin resistance at baseline examination.</p
Distribution of the patients according to present treatment-related factors (n = 259).</p
<p>Distribution of replicate samples for seven classes of treatment: Control, PA-4 hrs, PA-24 hrs, F...
<p>* Net of trials where the phase is not specified.</p><p>Distribution of interventional clinical t...
<p>Distribution of the five different AOIs over the visual field for the assessment of HGD.</p
<p>Distributions of total number of hemophilia A cases and number of rehabilitation users in terms o...
<p>Distribution of ICDAS scores in relation to the histological scores from SM (between brackets) an...
<p>Distribution of the CHA<sub>2</sub>DS<sub>2</sub>-VASc and the HAS-BLED Score of all patients on ...
<p>Distribution of episodes by number of lines of treatment contained therein, compared for TRD and ...
<p>Distribution of reported false and indeterminate results by tester profession in PT1 and PT2.</p
<p>Percentage of IVD tests T% with indices , , and within tolerance levels for different treatment ...
Distribution of mild, moderate, and severe patients, based on the five approaches used in the study....
<p>The reported legend in the figure shows the dose distribution considered in this plan.</p
Distribution of cases in the training sets obtained from different hospitals (A-D).</p
Distribution of the experimental groups according to treatment received, ethanasia times, and treatm...
Distribution of surrogate measures for insulin resistance at baseline examination.</p
Distribution of the patients according to present treatment-related factors (n = 259).</p
<p>Distribution of replicate samples for seven classes of treatment: Control, PA-4 hrs, PA-24 hrs, F...
<p>* Net of trials where the phase is not specified.</p><p>Distribution of interventional clinical t...
<p>Distribution of the five different AOIs over the visual field for the assessment of HGD.</p
<p>Distributions of total number of hemophilia A cases and number of rehabilitation users in terms o...
<p>Distribution of ICDAS scores in relation to the histological scores from SM (between brackets) an...
<p>Distribution of the CHA<sub>2</sub>DS<sub>2</sub>-VASc and the HAS-BLED Score of all patients on ...
<p>Distribution of episodes by number of lines of treatment contained therein, compared for TRD and ...
<p>Distribution of reported false and indeterminate results by tester profession in PT1 and PT2.</p
DOI
Add to ORKG